Properties of post-infusion factor VIII in von Willebrand's disease.
D000818:Animals; D000941:Antigens / Q000032:analysis; D001803:Blood Transfusion; D002417:Cattle; D002850:Chromatography, Gel; D003450:Cryoglobulins / Q000627:therapeutic use; D004586:Electrophoresis; D005169:Factor VIII / Q000032:analysis* / Q000276:immunology; D005615:Freezing; D006720:Homozygote; D006863:Hydrogen-Ion Concentration; D008297:Male; D008970:Molecular Weight; D010974:Platelet Aggregation / Q000187:drug effects; D011817:Rabbits / Q000276:immunology; D012310:Ristocetin / Q000494:pharmacology; D013917:Thrombin; D013997:Time Factors; D014842:von Willebrand Diseases / Q000097:blood / Q000235:genetics / Q000276:immunology / Q000628:therapy*
D000941:Antigens; D003450:Cryoglobulins; D012310:Ristocetin; D005169:Factor VIII; D013917:Thrombin